Imitrex and Herniated nucleus pulposus (slipped disk) - a phase IV clinical study of FDA data

Summary:

Herniated nucleus pulposus (slipped disk) is reported as a side effect among people who take Imitrex (sumatriptan succinate), especially for people who are female, 50-59 old, also take Flexeril, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Herniated nucleus pulposus (slipped disk) when taking Imitrex. It is created by eHealthMe based on reports of 15,815 people who have side effects when taking Imitrex from the FDA, and is updated regularly.

What is Imitrex?

Imitrex has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 17,149 Imitrex users. Check the latest studies of Imitrex.

What is Herniated nucleus pulposus (slipped disk)?

Herniated nucleus pulposus (slipped disk) is found to be associated with 582 drugs and 909 conditions by eHealthMe. Check the latest studies of Herniated nucleus pulposus (slipped disk).

On Aug, 02, 2026

15,815 people reported to have side effects when taking Imitrex.
Among them, 11 people (0.07%) have Herniated nucleus pulposus (slipped disk).

Could Imitrex cause Herniated nucleus pulposus (slipped disk)?

Among these 11 people:

What is the gender of people who have Herniated nucleus pulposus (slipped disk) when taking Imitrex? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Herniated nucleus pulposus (slipped disk) when taking Imitrex? *

What are other drugs people take besides Imitrex? *

What are other side effects people have besides Herniated nucleus pulposus (slipped disk)? *

Intervertebral Disc Degeneration (spinal disc degeneration): 5 people, 45.45%
Osteoporosis (bones weak and more likely to break): 5 people, 45.45%
Spinal Osteoarthritis (joint cartilage loss in spine): 4 people, 36.36%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 36.36%
Joint Pain: 4 people, 36.36%
Back Pain: 4 people, 36.36%
Depression: 4 people, 36.36%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 27.27%
Pain In Extremity: 3 people, 27.27%
Chest Pain: 3 people, 27.27%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 45.45%
High Blood Pressure: 4 people, 36.36%
Pain: 4 people, 36.36%
High Blood Cholesterol: 3 people, 27.27%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 18.18%
Tension Headache: 2 people, 18.18%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 18.18%
Headache (pain in head): 2 people, 18.18%
Multiple Allergies (allergy to multiple agents): 2 people, 18.18%
Depression: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Imitrex and have Herniated nucleus pulposus (slipped disk)?

- Check whether Herniated nucleus pulposus (slipped disk) is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imitrex:

Imitrex (17,149 reports)

Herniated nucleus pulposus (slipped disk) treatments and more:

Herniated nucleus pulposus (slipped disk) (5,608 reports)

How severe was Herniated nucleus pulposus (slipped disk) and when was it recovered:

Herniated nucleus pulposus (slipped disk) in Imitrex

Expand to all the drugs that have ingredients of sumatriptan succinate:

Herniated nucleus pulposus (slipped disk) and drugs with ingredients of sumatriptan succinate (21 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imitrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Herniated nucleus pulposus (slipped disk):

Herniated nucleus pulposus (slipped disk) (582 drugs)

Browse all the conditions that are associated with Herniated nucleus pulposus (slipped disk):

Herniated nucleus pulposus (slipped disk) (909 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Imitrex) and Imitrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.